Phoenix, AZ, March 28, 2007—The NIH Neuroscience Microarray Consortium today announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services.

Stan Nelson, the principal investigator at UCLA, says that "adding ultra-high throughput genotyping for its user-base of ~10,000 investigators across the world keeps the Consortium current with the ...

The NIH Neuroscience Microarray Consortium has announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services. Stan Nelson, the principal ...

Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application ...

For most researchers DNA microarrays are synonymous with high-throughput gene expression analysis. But they also are invaluable genotyping tools. Now that the International HapMap Project (see article ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

The Genotyping Assay Market refers to the industry segment that develops and offers assays, kits, platforms, and services for determining genetic variations among individuals, including single ...

We offer genotyping and microarray gene expression analyses using Thermofisher (formerly known as Affymetrix) array platforms. We are one of only a handful of labs in Europe to offer high throughput ...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme. Eurofins Genomics will be ...